China Pharma Correlations
CPHI Stock | USD 0.20 0.01 5.26% |
The current 90-days correlation between China Pharma Holdings and Bio Path Holdings is 0.08 (i.e., Significant diversification). The correlation of China Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
China Pharma Correlation With Market
Good diversification
The correlation between China Pharma Holdings and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and DJI in the same portfolio, assuming nothing else is changed.
China |
Moving together with China Stock
Moving against China Stock
0.56 | FBRX | Forte Biosciences Trending | PairCorr |
0.51 | VCNX | Vaccinex | PairCorr |
0.48 | KRYS | Krystal Biotech | PairCorr |
0.39 | NRSNW | NeuroSense Therapeutics | PairCorr |
0.36 | ERAS | Erasca Inc | PairCorr |
0.68 | NUVB | Nuvation Bio | PairCorr |
0.51 | APLS | Apellis Pharmaceuticals | PairCorr |
0.44 | RNXT | RenovoRx | PairCorr |
0.43 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.37 | ROIV | Roivant Sciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between China Stock performing well and China Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze China Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CAPR | 6.80 | 2.66 | 0.50 | 16.70 | 4.10 | 18.22 | 69.31 | |||
SLNO | 2.19 | 0.26 | 0.11 | 0.35 | 2.18 | 6.31 | 13.33 | |||
BPTH | 4.04 | (0.41) | 0.00 | 5.61 | 0.00 | 6.67 | 51.22 | |||
MBRX | 3.83 | 0.35 | 0.04 | (0.62) | 4.30 | 9.75 | 35.41 | |||
CRNX | 1.71 | (0.01) | (0.01) | 0.11 | 2.43 | 3.67 | 16.75 | |||
ASMB | 2.91 | 0.05 | 0.00 | 0.25 | 4.40 | 8.49 | 24.80 | |||
TIL | 9.31 | 1.37 | 0.24 | 0.39 | 6.84 | 20.63 | 105.83 | |||
CTMX | 2.68 | (0.45) | 0.00 | (0.24) | 0.00 | 5.36 | 20.61 | |||
ACHL | 2.03 | 0.47 | 0.20 | 0.45 | 1.55 | 3.06 | 38.16 |